Clinical trial
Peripheral-blood Cell Purification for PBMCs (PCP-PBMCs) Injection for Knee Osteoarthritis (PCP-PBMCs-KOA)
NCT07703280 is registered in ClinicalTrials.gov with DuoGenic StemCells Corporation (DGSC) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Peripheral-blood Cell Purification for PBMCs (PCP-PBMCs) Injection for Knee Osteoarthritis (PCP-PBMCs-KOA)
- Lead sponsor
- DuoGenic StemCells Corporation (DGSC)
- Phase
- Phase 2/3
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- December 31, 2029
- Enrollment
- 240 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
knee osteoarthritis